Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.
2.

Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.

Zimetti F, De Vuono S, Gomaraschi M, Adorni MP, Favari E, Ronda N, Ricci MA, Veglia F, Calabresi L, Lupattelli G.

J Lipid Res. 2017 Oct;58(10):2051-2060. doi: 10.1194/jlr.P076463. Epub 2017 Aug 22.

3.

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Bigazzi F, Adorni MP, Puntoni M, Sbrana F, Lionetti V, Pino BD, Favari E, Recchia FA, Bernini F, Sampietro T.

J Atheroscler Thromb. 2017 Aug 1;24(8):853-862. doi: 10.5551/jat.37101. Epub 2016 Dec 15.

4.

Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.

Adorni MP, Cipollari E, Favari E, Zanotti I, Zimetti F, Corsini A, Ricci C, Bernini F, Ferri N.

Atherosclerosis. 2017 Jan;256:1-6. doi: 10.1016/j.atherosclerosis.2016.11.019. Epub 2016 Nov 16.

PMID:
27940374
5.

Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.

Zimetti F, Caffarra P, Ronda N, Favari E, Adorni MP, Zanotti I, Bernini F, Barocco F, Spallazzi M, Galimberti D, Ricci C, Ruscica M, Corsini A, Ferri N.

J Alzheimers Dis. 2017;55(1):315-320.

6.

Lomitapide affects HDL composition and function.

Yahya R, Favari E, Calabresi L, Verhoeven AJM, Zimetti F, Adorni MP, Gomaraschi M, Averna M, Cefalù AB, Bernini F, Sijbrands EJG, Mulder MT, Roeters van Lennep JE.

Atherosclerosis. 2016 Aug;251:15-18. doi: 10.1016/j.atherosclerosis.2016.05.005. Epub 2016 May 11.

7.

An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle.

Della Torre S, Mitro N, Fontana R, Gomaraschi M, Favari E, Recordati C, Lolli F, Quagliarini F, Meda C, Ohlsson C, Crestani M, Uhlenhaut NH, Calabresi L, Maggi A.

Cell Rep. 2016 Apr 12;15(2):360-71. doi: 10.1016/j.celrep.2016.03.019. Epub 2016 Mar 31.

8.

A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla).

Pisciotta L, Vitali C, Favari E, Fossa P, Adorni MP, Leone D, Artom N, Fresa R, Calabresi L, Calandra S, Bertolini S.

J Clin Lipidol. 2015 Nov-Dec;9(6):837-846. doi: 10.1016/j.jacl.2015.09.001. Epub 2015 Sep 18.

9.

Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease.

Zimetti F, Favari E, Cagliero P, Adorni MP, Ronda N, Bonardi R, Gomaraschi M, Calabresi L, Bernini F, Guardamagna O.

Atherosclerosis. 2015 Oct;242(2):443-9. doi: 10.1016/j.atherosclerosis.2015.08.007. Epub 2015 Aug 10.

PMID:
26291497
10.

Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.

Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, Mikkelsen K, Borghi MO, Favalli EG, Gatti R, Hollan I, Meroni PL, Bernini F.

Arthritis Rheumatol. 2015 May;67(5):1155-64. doi: 10.1002/art.39039.

11.

Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions.

Montecucco F, Favari E, Norata GD, Ronda N, Nofer JR, Vuilleumier N.

Handb Exp Pharmacol. 2015;224:455-82. doi: 10.1007/978-3-319-09665-0_14. Review.

PMID:
25522998
12.

Cholesterol efflux and reverse cholesterol transport.

Favari E, Chroni A, Tietge UJ, Zanotti I, Escolà-Gil JC, Bernini F.

Handb Exp Pharmacol. 2015;224:181-206. doi: 10.1007/978-3-319-09665-0_4. Review.

PMID:
25522988
13.

The natural compound berberine positively affects macrophage functions involved in atherogenesis.

Zimetti F, Adorni MP, Ronda N, Gatti R, Bernini F, Favari E.

Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):195-201. doi: 10.1016/j.numecd.2014.08.004. Epub 2014 Aug 30.

PMID:
25240689
14.

Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia.

Vigna GB, Satta E, Bernini F, Boarini S, Bosi C, Giusto L, Pinotti E, Tarugi P, Vanini A, Volpato S, Zimetti F, Zuliani G, Favari E.

Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):777-83. doi: 10.1016/j.numecd.2014.02.010. Epub 2014 Mar 1.

PMID:
24680225
15.

Hydrocortisone directly promotes cholesterol accumulation in macrophages.

Greco D, Favari E, Adorni MP, Zimetti F, Gatti R, Bernini F, Ronda N.

Ann Rheum Dis. 2014 Jun;73(6):1274-6. doi: 10.1136/annrheumdis-2013-204806. Epub 2014 Jan 15. No abstract available.

PMID:
24431389
16.

Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.

Franceschini G, Favari E, Calabresi L, Simonelli S, Bondioli A, Adorni MP, Zimetti F, Gomaraschi M, Coutant K, Rossomanno S, Niesor EJ, Bernini F, Benghozi R.

J Clin Lipidol. 2013 Sep-Oct;7(5):414-22. doi: 10.1016/j.jacl.2013.06.007. Epub 2013 Jun 27.

PMID:
24079282
17.

Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome.

Gomaraschi M, Ossoli A, Favari E, Adorni MP, Sinagra G, Cattin L, Veglia F, Bernini F, Franceschini G, Calabresi L.

Cardiovasc Res. 2013 Oct 1;100(1):36-43. doi: 10.1093/cvr/cvt169. Epub 2013 Jun 28.

PMID:
23812298
18.

Rac1 and cholesterol metabolism in macrophage.

Adorni MP, Ronda N, Bernini F, Favari E.

J Cardiovasc Pharmacol. 2013 Nov;62(5):418-24. doi: 10.1097/FJC.0b013e31829dd874. Review.

PMID:
23792701
19.

Functional and morphological vascular changes in subjects with familial combined hypolipidemia: an exploratory analysis.

Minicocci I, Cantisani V, Poggiogalle E, Favari E, Zimetti F, Montali A, Labbadia G, Pigna G, Pannozzo F, Zannella A, Ceci F, Ciociola E, Santini S, Maranghi M, Vestri A, Ricci P, Bernini F, Arca M.

Int J Cardiol. 2013 Oct 9;168(4):4375-8. doi: 10.1016/j.ijcard.2013.05.053. Epub 2013 May 28. No abstract available.

PMID:
23722053
20.

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus.

Ronda N, Favari E, Borghi MO, Ingegnoli F, Gerosa M, Chighizola C, Zimetti F, Adorni MP, Bernini F, Meroni PL.

Ann Rheum Dis. 2014 Mar;73(3):609-15. doi: 10.1136/annrheumdis-2012-202914. Epub 2013 Apr 5.

PMID:
23562986
21.

ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects.

Favari E, Ronda N, Adorni MP, Zimetti F, Salvi P, Manfredini M, Bernini F, Borghi C, Cicero AF.

J Lipid Res. 2013 Jan;54(1):238-43. doi: 10.1194/jlr.P030452. Epub 2012 Oct 28.

22.

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.

Fasano T, Zanoni P, Rabacchi C, Pisciotta L, Favari E, Adorni MP, Deegan PB, Park A, Hlaing T, Feher MD, Jones B, Uzak AS, Kardas F, Dardis A, Sechi A, Bembi B, Minuz P, Bertolini S, Bernini F, Calandra S.

Mol Genet Metab. 2012 Nov;107(3):534-41. doi: 10.1016/j.ymgme.2012.08.005. Epub 2012 Aug 18.

PMID:
22959828
23.

Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.

Adorni MP, Zimetti F, Puntoni M, Bigazzi F, Sbrana F, Minichilli F, Bernini F, Ronda N, Favari E, Sampietro T.

J Lipid Res. 2012 May;53(5):984-9. doi: 10.1194/jlr.P024810. Epub 2012 Mar 12.

24.

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.

Pisciotta L, Favari E, Magnolo L, Simonelli S, Adorni MP, Sallo R, Fancello T, Zavaroni I, Ardigò D, Bernini F, Calabresi L, Franceschini G, Tarugi P, Calandra S, Bertolini S.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):42-50. doi: 10.1161/CIRCGENETICS.111.960674. Epub 2011 Nov 7.

PMID:
22062970
25.

Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations.

Zanotti I, Favari E, Bernini F.

Curr Pharm Biotechnol. 2012 Feb;13(2):292-302. Review.

PMID:
21470124
26.

Free cholesterol alters macrophage morphology and mobility by an ABCA1 dependent mechanism.

Adorni MP, Favari E, Ronda N, Granata A, Bellosta S, Arnaboldi L, Corsini A, Gatti R, Bernini F.

Atherosclerosis. 2011 Mar;215(1):70-6. doi: 10.1016/j.atherosclerosis.2010.12.004. Epub 2010 Dec 15.

PMID:
21215399
27.

Structure and function of the apoA-IV T347S and Q360H common variants.

Gomaraschi M, Putt WE, Pozzi S, Iametti S, Barbiroli A, Bonomi F, Favari E, Bernini F, Franceschini G, Talmud PJ, Calabresi L.

Biochem Biophys Res Commun. 2010 Feb 26;393(1):126-30. doi: 10.1016/j.bbrc.2010.01.099. Epub 2010 Feb 1.

PMID:
20117098
28.

Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1.

Favari E, Calabresi L, Adorni MP, Jessup W, Simonelli S, Franceschini G, Bernini F.

Biochemistry. 2009 Nov 24;48(46):11067-74. doi: 10.1021/bi901564g.

PMID:
19839639
29.

A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a Caucasian kindred.

Calabresi L, Nilsson P, Pinotti E, Gomaraschi M, Favari E, Adorni MP, Bernini F, Sirtori CR, Calandra S, Franceschini G, Tarugi P.

Atherosclerosis. 2009 Aug;205(2):506-11. doi: 10.1016/j.atherosclerosis.2009.01.006. Epub 2009 Jan 15.

PMID:
19200546
30.

Functional LCAT is not required for macrophage cholesterol efflux to human serum.

Calabresi L, Favari E, Moleri E, Adorni MP, Pedrelli M, Costa S, Jessup W, Gelissen IC, Kovanen PT, Bernini F, Franceschini G.

Atherosclerosis. 2009 May;204(1):141-6. doi: 10.1016/j.atherosclerosis.2008.08.038. Epub 2008 Sep 6.

PMID:
18922527
31.

The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.

Zanotti I, Potì F, Pedrelli M, Favari E, Moleri E, Franceschini G, Calabresi L, Bernini F.

J Lipid Res. 2008 May;49(5):954-60. doi: 10.1194/jlr.M700254-JLR200. Epub 2008 Feb 5.

32.

A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux.

Favari E, Gomaraschi M, Zanotti I, Bernini F, Lee-Rueckert M, Kovanen PT, Sirtori CR, Franceschini G, Calabresi L.

J Biol Chem. 2007 Feb 23;282(8):5125-32. Epub 2006 Dec 12.

33.

Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients.

Franceschini G, Calabresi L, Colombo C, Favari E, Bernini F, Sirtori CR.

Atherosclerosis. 2007 Dec;195(2):385-91. Epub 2006 Nov 15.

PMID:
17109866
34.

Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.

Zanotti I, Potì F, Favari E, Steffensen KR, Gustafsson JA, Bernini F.

J Pharmacol Exp Ther. 2006 Apr;317(1):395-401. Epub 2006 Jan 13.

PMID:
16415093
35.

Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages.

Duong M, Collins HL, Jin W, Zanotti I, Favari E, Rothblat GH.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):541-7. Epub 2006 Jan 12.

PMID:
16410457
36.

Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages.

Favari E, Zimetti F, Bortnick AE, Adorni MP, Zanotti I, Canavesi M, Bernini F.

FEBS Lett. 2005 Dec 5;579(29):6537-42. Epub 2005 Nov 2.

37.

Probucol inhibits ABCA1-mediated cellular lipid efflux.

Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, Rothblat GH.

Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2345-50. Epub 2004 Oct 28.

PMID:
15514211
38.

Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells.

Zanotti I, Favari E, Sposito AC, Rothblat GH, Bernini F.

Biochem Biophys Res Commun. 2004 Aug 27;321(3):670-4.

PMID:
15358158
39.

Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.

Favari E, Lee M, Calabresi L, Franceschini G, Zimetti F, Bernini F, Kovanen PT.

J Biol Chem. 2004 Mar 12;279(11):9930-6. Epub 2003 Dec 29.

40.

Identification and characterization of rodent ABCA1 in isolated type II pneumocytes.

Bortnick AE, Favari E, Tao JQ, Francone OL, Reilly M, Zhang Y, Rothblat GH, Bates SR.

Am J Physiol Lung Cell Mol Physiol. 2003 Oct;285(4):L869-78. Epub 2003 Aug 8.

41.

The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux.

Favari E, Bernini F, Tarugi P, Franceschini G, Calabresi L.

Biochem Biophys Res Commun. 2002 Dec 20;299(5):801-5.

PMID:
12470649
42.

Cellular cholesterol flux studies: methodological considerations.

Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G.

Atherosclerosis. 2002 Jul;163(1):1-8.

PMID:
12048116
43.

Scavenger receptor class B type I affects cholesterol homeostasis by magnifying cholesterol flux between cells and HDL.

de La Llera-Moya M, Connelly MA, Drazul D, Klein SM, Favari E, Yancey PG, Williams DL, Rothblat GH.

J Lipid Res. 2001 Dec;42(12):1969-78.

44.

Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages.

Bellosta S, Canavesi M, Favari E, Cominacini L, Gaviraghi G, Fumagalli R, Paoletti R, Bernini F.

J Pharmacol Exp Ther. 2001 Mar;296(3):736-43. Erratum in: J Pharmacol Exp Ther 2001 May;297(2):827.

45.

Cellular toxicity of N-substituted 2,2'-dicarboxamidodiphenyldisulphides with high antimicrobial activity.

Favari E, Bernardini E, Bernini F, Mazza P, Zani F.

Pharmacol Res. 1999 Nov;40(5):429-34.

PMID:
10527658

Supplemental Content

Loading ...
Support Center